Showing results (1061-1070 of 1,139) with videos related to
Sort By:
Pageof 114
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2021
Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colorectal Cancer After 16 Weeks of First-Line Therapy: Results of the Randomized FOCUS4-N TrialRichard A Adams, David J Fisher, Janet Graham, et al.Clinical and Experimental Medicine|December 3, 2025
Cuproptosis in lung cancer: a nexus of ncRNA regulation, epigenetics, and tumor microenvironment RemodelingMohamed S Imam, Randa M Abdel-Sattar, Nasser M Aldekhail, et al.Asiaintervention|December 16, 2021
Asia Pacific TAVI registry (an APSIC initiative): initial report of early outcomes: Asia Pacific TAVI registryEdgar Tay, Thet Khaing, Wei Hsian Yin, et al.Journal of Interventional Cardiology|August 8, 2022
Patient Characteristics, Procedural Details, and Outcomes of Contemporary Percutaneous Coronary Intervention in Real-World Practice: Insights from Nationwide Thai PCI RegistryNakarin Sansanayudh, Mann Chandavimol, Suphot Srimahachota, et al.ESMO Open|June 25, 2026
Prognostic markers, quality of life (QoL) and value of health (V-He) in advanced biliary cancers (ABC) treated with second-line active symptom control (ASC) alone or ASC with oxaliplatin-5-FU chemotherapy (ASC + FOLFOX) in the randomised phase III, multicentre, open-label ABC-06 clinical trialA Lamarca, D H Palmer, H S Wasan, et al.Eclinicalmedicine|April 19, 2021
Stratified care to prevent chronic low back pain in high-risk patients: The TARGET trial. A multi-site pragmatic cluster randomized trialAnthony Delitto, Charity G Patterson, Joel M Stevans, et al.Future Oncology (London, England)|July 29, 2025
ABC-12: exploring the microbiome in patients with advanced biliary tract cancer in a first-line study of durvalumab (MEDI4736) in combination with cisplatin/gemcitabineEleni Vrana, Hayley Timmins, Ashley Osborne, et al.The Lancet. Oncology|March 6, 2017
Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trialGary Middleton, Daniel H Palmer, William Greenhalf, et al.Immunity|September 10, 2014
Human dermal CD14⁺ cells are a transient population of monocyte-derived macrophagesNaomi McGovern, Andreas Schlitzer, Merry Gunawan, et al.Journal of Vascular Surgery. Venous and Lymphatic Disorders|November 3, 2022
The 2022 Society for Vascular Surgery, American Venous Forum, and American Vein and Lymphatic Society clinical practice guidelines for the management of varicose veins of the lower extremities. Part I. Duplex Scanning and Treatment of Superficial Truncal Reflux: Endorsed by the Society for Vascular Medicine and the International Union of PhlebologyPeter Gloviczki, Peter F Lawrence, Suman M Wasan, et al.Pageof 114